Variable, diversity and joining gene segment (V(D)J) recombination assembles immunoglobulin heavy or light chain (IgH or IgL) variable region exons in developing bone marrow B cells, whereas class switch recombination (CSR) exchanges IgH constant region exons in peripheral B cells. Both processes use directed DNA double-strand breaks (DSBs) repaired by non-homologous end-joining (NHEJ). Errors in either V(D)J recombination or CSR can initiate chromosomal translocations, including oncogenic IgH locus (Igh) to c-myc (also known as Myc) translocations of peripheral B cell lymphomas. Collaboration between these processes has also been proposed to initiate translocations. However, the occurrence of V(D)J recombination in peripheral B cells is controversial. Here we show that activated NHEJ-deficient splenic B cells accumulate V(D)J-recombination-associated breaks at the lambda IgL locus (Igl), as well as CSR-associated Igh breaks, often in the same cell. Moreover, Igl and Igh breaks are frequently joined to form translocations, a phenomenon associated with specific Igh-Igl co-localization. Igh and c-myc also co-localize in these cells; correspondingly, the introduction of frequent c-myc DSBs robustly promotes Igh-c-myc translocations. Our studies show peripheral B cells that attempt secondary V(D)J recombination, and determine a role for mechanistic factors in promoting recurrent translocations in tumours. . Such recurrent oncogenic translocations are thought to represent highly selected, very low frequency events. Even so, aspects of c-myc, beyond coding sequences, may increase its translocation fequency 17 . In this regard, loci involved in recurrent oncogenic translocations often are spatially proximal within interphase nuclei [18] [19] [20] [21] [22] [23] . RAG and AID have been implicated in collaboratively initiating oncogenic translocations in human bonemarrow-derived pro-B/pre-B lymphomas 24, 25 . Many oncogenic translocations in mature B lymphomas occur during attempted CSR and involve AID-initiated breaks [26] [27] [28] [29] ; but others result from RAG-initiated DSBs 15, 30, 31 . Owing to checkpoint defects, RAG-initiated Igh breaks in ATM-deficient bone marrow pro-B cells persist and can be translocation substrates in IgM  1 . Conditional inactivation of loxP-flanked Xrcc4 in p53-deficient peripheral B cells using a CD21-Cre transgene leads to recurrent CD21-Cre-inactivated XRCC4 plus p53-deficient ('CXP') B cell lymphomas that contain aberrant Igk and Igl V(D)J rearrangements, Igh CSR events, and Igl and/or Igh-c-myc translocations 36 . We proposed CXP tumour progenitors to be peripheral B cells that undergo secondary V(D)J recombination and CSR
Surface IgM 1 B cells downregulate RAG and migrate to peripheral lymphoid tissues (for example, spleen) where they participate in antigen-dependent responses including CSR 8 . The various sets of germline Igh constant region exons ('C H genes') are flanked by switch (S) regions 9 . Activation-induced cytidine deaminase (AID, also known as AICDA) initiates DSBs in both Sm and a downstream S region, which are then joined by NHEJ or, in its absence, by less efficient microhomology-mediated alternative end-joining 9, 10 . This replaces Cm with a downstream C H gene to complete CSR (Supplementary Fig. 1 ). Germinal centre B cells have been argued to undergo antigen-dependent secondary V(D)J recombination, termed receptor revision, as a means of diversification 11 . Like receptor editing, receptor revision is proposed to target Igk and Igl, but to be distinct in location and activation mechanism 11, 12 . Whether or not V(D)J recombination actually occurs in the context of receptor revision in germinal centre B cells has been debated [11] [12] [13] [14] . Human and mouse B lymphomas often contain clonal translocations linking oncogenes, such as c-myc, to Igh, Igk or Igl 15, 16 . Such recurrent oncogenic translocations are thought to represent highly selected, very low frequency events. Even so, aspects of c-myc, beyond coding sequences, may increase its translocation fequency 17 . In this regard, loci involved in recurrent oncogenic translocations often are spatially proximal within interphase nuclei [18] [19] [20] [21] [22] [23] . RAG and AID have been implicated in collaboratively initiating oncogenic translocations in human bonemarrow-derived pro-B/pre-B lymphomas 24, 25 . Many oncogenic translocations in mature B lymphomas occur during attempted CSR and involve AID-initiated breaks [26] [27] [28] [29] ; but others result from RAG-initiated DSBs 15, 30, 31 . Owing to checkpoint defects, RAG-initiated Igh breaks in ATM-deficient bone marrow pro-B cells persist and can be translocation substrates in IgM 1 peripheral B cells 32 . Thus far, however, translocations have not been shown to result from RAG activity in peripheral B cells.
XRCC4 is a critical NHEJ component 2 . In its absence, V(D)J recombination is abrogated 33, 34 and CSR is impaired 10, 35 . Conditional inactivation of loxP-flanked Xrcc4 in p53-deficient peripheral B cells using a CD21-Cre transgene leads to recurrent CD21-Cre-inactivated XRCC4 plus p53-deficient ('CXP') B cell lymphomas that contain aberrant Igk and Igl V(D)J rearrangements, Igh CSR events, and Igl and/or Igh-c-myc translocations 36 . We proposed CXP tumour progenitors to be peripheral B cells that undergo secondary V(D)J recombination and CSR 36 . To search for such putative CXP tumour progenitors, we have now analysed splenic CD21-cre, Xrcc4 c/2 B cells, in which Xrcc4 was peripherally inactivated but p53 was left intact to obviate B cell lymphomas.
Igh breaks in XRCC4-deficient B cells are AID-dependent CD21-cre, Xrcc4 c/2 mice have normal IgM 1 B cell numbers, because Xrcc4 is intact for primary V(D)J recombination in developing bone marrow B cells, with inactivation starting in transitional-stage peripheral B cells 10, 37 . (Fig. 1b) . After stimulation with anti-CD40 and IL4 for 4 days, we found Igl breaks in more than 1% of XRCC4-deficient B cells, with none in controls (Fig. 1b and  Supplementary Table 3) . Moreover, the Igl breaks were frequently translocated ( Fig. 1b and Supplementary Fig. 2 Supplementary Fig. 3 ). We also assayed for Igl breaks by three-dimensional (3D) interphase FISH with 59 Igl and 39 Igl probes (Fig. 1d) . Igl breaks were rare in resting (day 0) CD21-cre, Xrcc4 c/2 splenic B cells, but occurred in about 1.5% of day-4-activated XRCC4-deficient splenic B cells (Fig. 1d, Supplementary Fig. 4 and Supplementary Supplementary Fig. 4) . Bottom, quantification of Igl abnormalities by 3D interphase FISH on day 0 (n 5 3) or day 4 (n 5 3) splenic B cells activated with anti-CD40 and IL4. In all panels, data are presented as mean and s.e.m. Statistical analyses were calculated by a Student's t-test with two-tailed distribution.
and found a comparable frequency to that in CD21-cre, Xrcc4 c/2 B cells (Fig. 1b, c, Supplementary Tables 3 and 4 and Supplementary  Fig. 5 Fig. 6 ). Although Igh break frequency was comparable between CD21-cre, Xrcc4 c/2 and CD21-cre, Xrcc4 c/2 Rag2 c B cells, Igl break frequency was significantly reduced in CD21-cre, Xrcc4 c/2 Rag2 c B cells (Fig. 1a, b and Supplementary Tables 1 and 3 ). Thus, in activated CD21-cre, Xrcc4 c/2 splenic B cells, Igh breaks are AID-dependent and RAG-independent, whereas Igl breaks are AID-independent and mostly RAG-dependent. Igk breaks were not significantly reduced in activated CD21-cre, Xrcc4 c/2 Rag2 c B cells (Fig. 1c and Supplementary Table 4 ), suggesting that either they are not initiated by AID or RAG, or their earlier kinetic onset allows accumulation before RAG activity is eliminated.
RAG and AID collaborate to generate Igh-Igl translocations
We used sequential FISH to determine whether Igh, Igk or Igl breaks occurred simultaneously in CD21-cre, Xrcc4 c/2 B cell metaphases. Analyses of over 2,000 day 4 CD21-cre, Xrcc4 c/2 B cell metaphases activated with anti-CD40 and IL4 showed that none had both Igk and Igl breaks (Supplementary Fig. 7 ). However, analyses with a Jk-Ck probe showed that nearly 50% of metaphases with a broken Igl had deleted Jk-Ck on one or both alleles ( Supplementary Fig. 8 ), similar to secondary V(D)J recombination events in CXP B lymphomas 36 . We found one Igk-Igh translocation in over 2,000 activated CD21-cre, Xrcc4 c/2 B cell metaphases, consistent with a high frequency but at levels just below ready cytogenetic measurement ( Supplementary  Fig. 9a ). Nearly 60% of metaphases with Igl breaks also had Igh breaks and/or translocations and about 20% of these retained both centric and acentric portions of chromosomes 12 and 16 ( Supplementary  Figs 7, 9b, c and data not shown) , suggesting attempted V(D)J recombination and CSR in the same or successive cell cycles. In this regard, combined FISH with Igl and Igh probes and chromosome paints showed that 30% of Igl translocations involved Igh (for example, Fig. 2a and Supplementary Fig. 9b, c) . Because many IghIgl translocations resulted in dicentrics with 39 Igl and 39 Igh probes juxtaposed ( Supplementary Fig. 9b ), we performed FISH with these probes simultaneously, which showed AID-dependent Igh-Igl translocations in about 0.2% of CD21-cre, Xrcc4 c/2 B cells (Fig. 2a,  Supplementary Table 8 and Supplementary Fig. 10 ). Thus, unrepaired RAG-dependent Igl breaks in activated CD21-cre, Xrcc4 c/2 splenic B cells are frequently fused to AID-dependent Igh breaks in the same cell to form chromosome 12/16 translocations.
We isolated Igh-Igl translocation junctions from CD21-cre, Xrcc4 c/2 B cells using PCR ( Supplementary Fig. 10 ), and found most fused Sm to sequences downstream of Jl1/Jl3 V(D)J recombination signal sequences (Fig. 2b and Supplementary Fig. 11 ). Consistent with AID-initiated Igh breaks joined to RAG-initiated Igl breaks, point mutations and other alterations were observed in Igh-but not Iglderived junctional sequences ( Supplementary Fig. 11 ). Consistent with RAG-initiated breaks resolved in the absence of NHEJ, Igl junctions were at variable distances downstream of Jl1 and Jl3. Furthermore, most Igh/Igl junctions contained microhomologies indicative of alternative end-joining ( Supplementary Fig. 11 ). We conclude that, in activated splenic CD21-cre, Xrcc4 c/2 B cells, alternative end-joining joins RAG-induced Igl breaks to AID-initiated Igh breaks at high frequency.
Co-localization of Igh and Igl in B cell interphase nuclei 3D interphase FISH with 39 Igh and 39
Igl probes showed colocalization of the loci (#0.5 mm apart) in about 14% of resting (day 0) and 7-8% of day 3.5 anti-CD40-and IL4-activated control and CD21-cre, Xrcc4 c/2 splenic B cells (Fig. 3a-d and Supplementary  Tables 9 and 10 ). Because there are no Igh or Igl breaks in resting B cells (Fig. 1a, d) , and AID-initiated breaks begin at day 2 (ref. 41 Supplementary Fig. 11 . A vertical green arrow indicates breakpoints. For a given translocation, the same number is used to indicate the corresponding Igh and Igl breakpoints, with the Igh breakpoint denoted by a prime symbol.
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ARTICLES conclude that Igh and Igl co-localize before and after DSB induction, and that XRCC4 deficiency does not alter this association. To assess cell-type specificity, we assayed wild-type thymocyte and ES cell interphase nuclei and found only low-level Igh and Igl co-localization ( Fig. 3c and Supplementary Table 9 ). To examine specificity of the Igh and Igl association within chromosome 16, we tested co-localization of Igh with two control loci (C2 and K10), which map, respectively, about 15 Mb telomeric or centromeric to Igl (Fig. 3b) . Igh and C2 colocalization was at background levels in resting and activated B cells and thymocytes, whereas Igh and K10 co-localization occurred at substantially lower levels than Igh and Igl co-localization (Fig. 3c and Supplementary Table 11 ). Therefore, Igh and Igl co-localization is cell-type specific and focal on chromosome 16 with respect to Igl. Notably, Igh and Igk also co-localize specifically and focally, at least with respect to Igk, in about 5% of splenic B cells ( Supplementary  Fig. 12 and Supplementary Table 12 ).
DSBs in c-myc are rate-limiting for translocations
Given that CXP tumours routinely have Igh-c-myc translocations 36 , we tested for Igh and c-myc co-localization in B cell nuclei by 3D interphase FISH (Fig. 4b) . Approximately, 4-6% of resting, 15-min activated and 3.5-day activated control or CD21-cre, Xrcc4 c/2 B cell nuclei had co-localized Igh and c-myc signals (Fig. 4b, c 26 per cell) control levels ( Fig. 4a , Supplementary  Fig. 13 and Supplementary Table 15 ). On the basis of frequent Igh breaks and Igh-c-myc co-localization, we hypothesized c-myc breaks to be rate-limiting for Igh-c-myc translocations. To test this, we introduced 25 tandemly arrayed ISceI endonuclease target sites 42 into the c-myc first intron to create the c-myc 25IsceI allele ( Fig. 4d and Supplementary Fig. 14) . Then, anti-CD40-and IL4-activated peripheral B cells heterozygous for the c-myc 25IsceI allele (c-myc ) were infected with ISceI-expressing or control retrovirus 43 and assayed for c-myc breaks by metaphase FISH. Notably, c-myc chromosomal breaks occurred in approximately 10% of c-myc 25ISceI/WT B cells infected with the ISceI virus, but were absent in the various control B cells (Fig. 4e and Supplementary Table 16 ). PCR quantification demonstrated that Igh-c-myc translocations in ISceIvirus-infected activated c-myc 25ISceI/WT B cells were increased by at least 100-fold compared to control levels (Fig. 4a, Supplementary Fig. 15 and Supplementary Table 16 ).
Discussion
We show that some activated CD21-cre, Xrcc4 c/2 splenic B cells contain characteristics of postulated 'editing and switching' CXP peripheral B cell lymphoma progenitors 36 , including Igk deletions, aberrant Igl V(D)J recombination, Igl translocations, and aberrant Igh CSR associated with Igh translocations to c-myc or Igl. Moreover, our studies clearly show V(D)J recombination-related events in CD21-cre, Xrcc4 c/2 splenic B cells; because they leave tell-tale RAG-dependent Igl breaks. Our cultured splenic B cells do not represent germinal centre B cells 44 , and CXP tumour progenitors do not seem to be of germinal centre origin 36 . Therefore, we suggest that V(D)J recombination events in activated CD21-cre, Xrcc4 c/2 splenic B cells and putative CXP lymphoma progenitors may represent peripheral editing mediated by low RAG expression, for example, as found in transitional B cells 8, 45, 46 . Although potential physiological roles for such a process are unknown, it may be relevant for peripheral B cells subjected to chronic activation, such as those in gut-associated lymphoid tissues where CXP tumours arise 36 . In this context, we find RAG-dependent Igl breaks in CD21-cre, Xrcc4 c/2 mesenteric lymph node B cells taken directly from mice (D.R.W. and F.W.A., unpublished data). Table 10 ). At least three mice were analysed per data set; data are presented as mean and s.e.m.
Our findings of RAG-initiated chromosomal breaks and translocations in XRCC4-deficient peripheral B cells raises the possibility that translocations in some human peripheral B cell lymphomas, such as follicular lymphomas, might be initiated by V(D)J recombination in the periphery 15, 30 . They also demonstrate that AID and RAG can collaborate to generate frequent Igh-Igl translocations in peripheral CD21-cre, Xrcc4 c/2 B cells. Notably, these Igh-Igl translocations offer no obvious cellular selective advantage; therefore, their appearance as clonal translocations in CXP lymphomas may simply reflect the frequent occurrence of these translocations in tumour progenitors due to mechanistic factors that include the two loci being frequently broken and spatially proximal. In the latter context, we have shown that the co-localization of two loci on different chromosomes can be quite focal, implicating aspects of particular loci themselves, beyond broader chromosomal territories 47 , as important factors in determining spatial proximity and translocation frequency. Furthermore, analyses of oncogenic translocations in NHEJ-deficient pro-B and B cell lymphomas 36, 48 suggest alternative end-joining may be translocation-prone relative to NHEJ 49, 50 . The high frequency of specific translocations catalysed by alternative end-joining in nontransformed CD21-cre, Xrcc4 c/2 B cells supports this notion.
METHODS SUMMARY
Generation of mouse strains. CD21-cre, Xrcc4 c/2 mice were generated as previously described 10 and crossed into AID-deficient mice 38 2 B cells were isolated from spleen, cultured, and assayed for CSR as previously described 10, 22 . Cells were sampled on various days for DNA isolation, flow cytometry analysis and metaphase preparation. Retroviral infection was performed as previously described 43 (see Methods). Two-colour FISH and telomere-FISH. Metaphase spreads from B cell cultures activated with anti-CD40 and IL4 were prepared and either two-colour FISH was used to detect Igh, Igk, Igl or c-myc chromosomal aberrations or telomere staining (T-FISH) was used to detect general aberrations as previously described 10 . FISH probes are detailed in Methods. 3D interphase FISH. 3D FISH was performed as described 32 (see Methods). Images of approximately 50 serial optical sections spaced by 0.2 mm were captured with Marianas spinning disk confocal microscope (363) with a CCD detector (Intelligent Imaging Innovations) and analysed with Slidebook software (Intelligent Imaging Innovations). PCR assay to detect Igh-c-myc or Igh-Igl translocations. Igh-c-myc translocation junctions were amplified by PCR from genomic DNA prepared from splenic B cells activated with anti-CD40 and IL4, using primers as described 26 . PCR products were run on agarose gels and hybridized with an internal c-myc oligonucleotide. Igh-Igl translocations were amplified using nested primers for Sm and Jl. PCR products were hybridized with Jl and Igh probes; the bands positive for both probes were cloned into the pGEM-T vector (Promega), sequenced and analysed using Lasergene software and the NCBI database. Primer sequences and PCR conditions are detailed in Methods. Supplementary Table 16 ). High titre retrovirus infection seems to inhibit end-joining allowing break visualization (see Methods).
